Welcome from Dartisla ODT!
Edenbridge Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere.
Founded in 2008, we launched our first product in February 2010 and have sold our commercial products through every major channel of the U.S. prescription pharmaceutical supply chain. In addition, we have a robust product development pipeline that includes 505(b)(2) NDAs, ANDAs, and foreign filings.
Edenbridge is proud to announce the launch of Dartisla ODT, the first and only orally disintegrating tablet of glycopyrrolate. Please visit Dartisla.com for more information.
Brands: Dartisla ODT